| Candice Widuch-mert, MD | |
|
1481 Eisenhower Blvd, Johnstown, PA 15904-3217 | |
| (814) 298-7428 | |
| (814) 536-1044 |
| Full Name | Candice Widuch-mert |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 16 Years |
| Location | 1481 Eisenhower Blvd, Johnstown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902242050 | NPI | - | NPPES |
| MD458967 | Other | PA | PA MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MT203563 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Conemaugh Memorial Medical Center | Johnstown, PA | Hospital |
| Entity Name | Apogee Medical Group Of Pennsylvania Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568633535 PECOS PAC ID: 2668437104 Enrollment ID: O20041124000275 |
News Archive
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
Exome sequencing can identify a likely genetic cause of 46,XY disorders of sex development in about a third of cases, report researchers.
Huntsman Cancer Institute at the University of Utah has been awarded a five-year, $3 million grant from the Centers for Disease Control and Prevention to improve Utah's colorectal cancer screening rates.
Porvair Sciences has announced an application note describing the excellent results achievable from a new 96-well format version of its ChromaTrap chromatin immunoprecipitation assay technology.
› Verified 9 days ago
| Entity Name | Hazleton Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952464638 PECOS PAC ID: 8022110402 Enrollment ID: O20070305000195 |
News Archive
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
Exome sequencing can identify a likely genetic cause of 46,XY disorders of sex development in about a third of cases, report researchers.
Huntsman Cancer Institute at the University of Utah has been awarded a five-year, $3 million grant from the Centers for Disease Control and Prevention to improve Utah's colorectal cancer screening rates.
Porvair Sciences has announced an application note describing the excellent results achievable from a new 96-well format version of its ChromaTrap chromatin immunoprecipitation assay technology.
› Verified 9 days ago
| Entity Name | Caring Healthcare Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417260266 PECOS PAC ID: 6002095254 Enrollment ID: O20110120000690 |
News Archive
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
Exome sequencing can identify a likely genetic cause of 46,XY disorders of sex development in about a third of cases, report researchers.
Huntsman Cancer Institute at the University of Utah has been awarded a five-year, $3 million grant from the Centers for Disease Control and Prevention to improve Utah's colorectal cancer screening rates.
Porvair Sciences has announced an application note describing the excellent results achievable from a new 96-well format version of its ChromaTrap chromatin immunoprecipitation assay technology.
› Verified 9 days ago
| Entity Name | Caring Healthcare Network Richland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659017754 PECOS PAC ID: 2062890809 Enrollment ID: O20220607000434 |
News Archive
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
Exome sequencing can identify a likely genetic cause of 46,XY disorders of sex development in about a third of cases, report researchers.
Huntsman Cancer Institute at the University of Utah has been awarded a five-year, $3 million grant from the Centers for Disease Control and Prevention to improve Utah's colorectal cancer screening rates.
Porvair Sciences has announced an application note describing the excellent results achievable from a new 96-well format version of its ChromaTrap chromatin immunoprecipitation assay technology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Candice Widuch-mert, MD 18 N Front St, Philipsburg, PA 16866-1602 Ph: (814) 342-2333 | Candice Widuch-mert, MD 1481 Eisenhower Blvd, Johnstown, PA 15904-3217 Ph: (814) 298-7428 |
News Archive
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
Exome sequencing can identify a likely genetic cause of 46,XY disorders of sex development in about a third of cases, report researchers.
Huntsman Cancer Institute at the University of Utah has been awarded a five-year, $3 million grant from the Centers for Disease Control and Prevention to improve Utah's colorectal cancer screening rates.
Porvair Sciences has announced an application note describing the excellent results achievable from a new 96-well format version of its ChromaTrap chromatin immunoprecipitation assay technology.
› Verified 9 days ago
Sai Harsha Bobba, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1086 Franklin St, Johnstown, PA 15905 Phone: 814-534-9364 Fax: 814-534-5599 | |
Bonifacio Tan Aguilera, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 307 Terlyn Drive, Johnstown, PA 15904 Phone: 814-467-6378 | |
Dr. Sahar Elias, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1450 Scalp Ave, Suite 1000, Johnstown, PA 15904 Phone: 814-269-5200 Fax: 814-269-5070 | |
Sandeep Mahal, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1086 Franklin St, Johnstown, PA 15905 Phone: 814-534-9364 | |
Fredrick William Munzer, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 411 Theatre Dr, Johnstown, PA 15904 Phone: 814-269-4507 Fax: 814-288-0194 | |
Erica Korin Wentz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1086 Franklin St, Johnstown, PA 15905 Phone: 814-534-9106 | |
Mark Mitchell Malicki, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 322 Warren St, Ste 300, Johnstown, PA 15905 Phone: 814-288-1418 Fax: 814-288-1525 |